{"version":"1.0","type":"link","title":"A Phase 1/2 multicenter trial of DKN-01 as monotherapy or in combination with docetaxel for the treatment of metastatic castration-resistant prostate cancer (mCRPC).","author_name":"Wise DR 외","author_url":"https://prs-insight.online/author/Wise%20DR","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/138744","thumbnail_width":1200,"thumbnail_height":630}